Energy metabolism, lipotropic support, liver fat metabolism, vitamin B-12
Lipo-B (MIC + B12)
A lipotropic blend of methionine, inositol, choline, and vitamin B12 commonly used to support energy metabolism, liver function, nutrient processing, and weight-management programs.
Administration Reference
Intramuscular
Source / Evidence Context
Commonly reported use — not established guidance
Dose Information
0.5mL – 1 mL per injection
Frequency
Once weekly
Duration / Cycle
4–12 weeks or continuous
Off-Cycle
No standard off-cycle
Timing
Morning or mid day
Storage Guidance
Room temperature, dark environment away from sunlight
Supplies
Affiliate disclosure: We may earn a commission if you purchase through these links.
Listings are not a required kit or confirmation of suitability for a particular peptide, formulation, or route. Check the product specifications and intended use.
Syringes & transfer supplies
BH Supplies Insulin Syringes U-100 29G 1ml/cc 1/2″ (12.7mm) Pack of 100 Pcs29g 1/2" syringePolybag, 100 Unit Capacity, 1/2” Needle Length, Bold Markings for Accurate Dosing, Disposable, Box of 100View at AMAZON →
Protective supplies & disposal
MED PRIDE Sterile Alcohol Prep Pads1 BOX OF 200INDIVIDUALLY WRAPPED ISOPROPYL ALCOHOL WIPES, PACK OF 1 BOX OF 200, MEDIUM SIZE PREP PADSView at AMAZON →
Inspire Black Nitrile Gloves HEAVY DUTY 6 Mil100ctView at AMAZON →
Square Sharps Container, 2 QuartQTY 1View at AMAZON →
Commonly Reported Uses
Energy support; metabolic support; weight-management programs; liver fat metabolism; vitamin B12 supplementation; fatigue support; nutrient metabolism; methylation support; exercise and health & wellness programs. Typically contains: L-carnitine, L-Arginine, Methonine, Inositol, Choline, B6 (Pyridoxine), B5 (dexpanthenol), B12(methylcobalamin)
Commonly Reported Indicators
Increased energy or stamina, reduced fatigue, improved exercise motivation, improved general well-being, and perceived support during weight-management programs are commonly reported. People who are B12 deficient may experience more noticeable improvement in fatigue or neurologic symptoms after B12 replacement.
Mechanism Overview
The MIC components participate in normal lipid and methyl-group metabolism. Choline is required for phosphatidylcholine production and hepatic lipid transport; methionine contributes methyl groups through S-adenosylmethionine; inositol participates in cell signaling and insulin-related pathways; and B12 is required for methionine synthase, fatty-acid metabolism, red blood cell production, and DNA synthesis.
Safety
Safety Considerations
Tolerance is generally influenced by the specific formulation and dose. Important considerations include hypersensitivity to B12 or cobalt, injection-site reactions, gastrointestinal symptoms, and the possibility of unnecessary high-dose nutrient exposure when baseline status is already sufficient. Because compounded MIC formulations vary, ingredient concentrations should be verified rather than assumed.
Reported Adverse Effects
Injection-site pain, redness, swelling or bruising; nausea; gastrointestinal discomfort; headache; anxiety or restlessness; transient flushing; and allergic reactions. B12 injections can rarely cause significant hypersensitivity reactions. Higher choline exposure can produce gastrointestinal effects, sweating, hypotension, or a fishy body odor.
Contraindications & Cautions
Known allergy to cobalt or B12; hypersensitivity to any formulation ingredient; pregnancy or breastfeeding unless specifically directed by a clinician; significant liver or kidney disease; markedly elevated B12 without an identified indication; and concurrent treatment where high-dose nutrient supplementation could interfere with medical management.
Status
Regulatory Status
Lipo-B/MIC+B12 is not an FDA-approved combination drug for weight loss or fat reduction. Individual ingredients such as injectable vitamin B12 have established medical uses, while MIC+B12 blends are commonly prepared by compounding pharmacies or wellness clinics. DailyMed has listed MIC-B12 injectable products under the regulatory category “unapproved drug other.”
Market Classification
Compounded medication
Status Notes
Lipo-B is a formulation category rather than a single standardized pharmaceutical product. Ingredient concentrations, B12 form, additives, dosing volume, and administration schedules vary between clinics and pharmacies. It should not be treated as equivalent to an FDA-approved obesity medication.
Research & Evidence
Evidence Level
Insufficient evidence
Research Last Reviewed
2026-09-06
Research Overview
The individual ingredients in Lipo-B have established biological roles and human research, but the combined MIC+B12 injection has not been studied to the same standard as modern weight-loss medications. Its strongest support is mechanistic and nutrient-specific, supplemented by extensive clinic use. The most defensible role is as metabolic and nutritional support rather than a stand-alone fat-loss therapy.
Human Research
Vitamin B12 has extensive human evidence for prevention and treatment of deficiency, including fatigue, anemia, and neurologic manifestations related to low B12 status. Injectable B12 bypasses gastrointestinal absorption and remains commonly used when malabsorption or deficiency is present.
Inositol has been studied extensively in metabolic conditions, particularly PCOS. A 2024 systematic review covering 30 randomized trials and 2,230 participants found possible improvements in selected metabolic measures, although results were inconsistent and evidence certainty was limited. These studies evaluate oral inositol rather than MIC injections.
Human choline research establishes its essential role in cell membranes, methyl-group metabolism, neurotransmitter synthesis, and normal liver function. Inadequate choline can contribute to hepatic and muscular abnormalities, supporting the biological rationale for adequate choline status without establishing injectable Lipo-B as a weight-loss treatment.
Animal Research
Animal and nutritional models have long established lipotropic effects of methionine and choline, particularly their roles in hepatic lipid export and prevention of abnormal liver-fat accumulation. These findings helped create the “lipotropic” terminology used for MIC formulations but do not directly establish weight-loss efficacy of injections in humans.
In Vitro Research
The individual components participate in well-characterized cellular pathways. Choline contributes to phosphatidylcholine and membrane synthesis; methionine feeds S-adenosylmethionine-dependent methylation; B12 supports methionine synthase and methylmalonyl-CoA mutase; and inositol derivatives function as intracellular second messengers involved in insulin and metabolic signaling.
References
Midwest Express Clinic. Lipo-B (MIC) Injections. Current clinic protocol and formulation overview.
Midwest Express Clinic. Spring Slim-Down: How Lipo-B Shots Can Support Your Wellness Goals. 2026.
National Institutes of Health, Office of Dietary Supplements. Vitamin B12 — Health Professional Fact Sheet. Updated July 2, 2025.
National Institutes of Health, Office of Dietary Supplements. Choline — Health Professional Fact Sheet.
Fitz V, Graca S, Mahalingaiah S, et al. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab. 2024;109(6):1630-1655. PMID 38163998. DOI 10.1210/clinem/dgad762.
DailyMed. MIC B12 Injection. NDC 70104-806. Intramuscular MIC+B12 formulation; marketing category: unapproved drug other.
ONIN. Intravenous and Intramuscular Injection Protocol of MIC Plus B12. 2024.
FormBlends Editorial Research. MIC B12 Injections Dosage: Complete Guide to Lipotropic Injection Protocols. Updated September 5, 2026.